Michael Gelband’s Usana Health Sciences USNA Stock Holding History

Michael Gelband’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,254	Closed	-$546K	–	2100
2026 Q1	$546K	Buy	31,254 +2,629	+9%	+$52.2K	﹤0.01%	1171
2025 Q4	$562K	Buy	28,625 +10,552	+58%	+$219K	﹤0.01%	1162
2025 Q3	$498K	Buy	+18,073	New	+$556K	0.01%	1185
2025 Q2	–	Sell	-40,572	Closed	-$1.09M	–	1996
2025 Q1	$1.09M	Buy	+40,572	New	+$1.28M	0.01%	894
2024 Q1	–	Sell	-27,089	Closed	-$1.45M	–	1984
2023 Q4	$1.45M	Buy	27,089 +15,052	+125%	+$761K	0.01%	680
2023 Q3	$705K	Buy	+12,037	New	+$753K	0.01%	1110
2023 Q2	–	Sell	-3,430	Closed	-$216K	–	2269
2023 Q1	$216K	Buy	+3,430	New	+$205K	﹤0.01%	1557
2022 Q4	–	Sell	-6,816	Closed	-$382K	–	2163
2022 Q3	$382K	Buy	+6,816	New	+$451K	0.01%	1454
2021 Q3	–	Sell	-3,306	Closed	-$339K	–	2660
2021 Q2	$339K	Buy	+3,306	New	+$332K	﹤0.01%	1671
2021 Q1	–	Sell	-4,827	Closed	-$372K	–	2638
2020 Q4	$372K	Buy	+4,827	New	+$373K	﹤0.01%	1423
2020 Q3	–	Sell	-20,277	Closed	-$1.49M	–	2252
2020 Q2	$1.49M	Buy	+20,277	New	+$1.59M	0.04%	553
2019 Q2	–	Sell	-3,039	Closed	-$255K	–	1343
2019 Q1	$255K	Buy	+3,039	New	+$317K	0.02%	504

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's USNA Position: Q2 2026 in Review

Michael Gelband sold out of Usana Health Sciences (USNA) in Q2 2026, closing a stake of 31,254 shares — an estimated $546K sold.

Michael Gelband first reported a position in USNA in Q1 2019 and held it in 12 quarters. The position peaked at $1.49M in Q2 2020. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Michael Gelband reported no remaining Usana Health Sciences position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 31,254 Usana Health Sciences shares in Q2 2026, an estimated $546K.
Michael Gelband first reported a position in Usana Health Sciences in Q1 2019 and held it in 12 quarters.
Michael Gelband's Usana Health Sciences position peaked at $1.49M in Q2 2020.
137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.